Gamma Biosciences, a provider of tools and technologies for cell and gene therapy manufacturing, through their BioMagnetic Solutions business, entered a strategic collaboration with Lonza. Under the multi-year agreement, BioMagnetic Solutions will supply its research and cGMP manufacturing grade FerroSelect reagents to Lonza for use in developing CAR-T and other immunotherapeutic products using Lonza’s Cocoon Platform.   The collaboration provides a framework for additional clinical ...